DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Actiq (Fentanyl Oral Transmucosal) - Adverse Event Reports - Disability - Intra-Uterine Death

 



Index of reports > Cases resulting in disability (2) > Cases with Intra-Uterine Death (1)

Below is the selection of adverse event reports related to Actiq (Fentanyl Oral Transmucosal) that includes cases resulting in disability where reactions include intra-uterine death.

Adverse event in 43 year old female receiving Actiq (Fentanyl Oral Transmucosal)

Reported by a consumer/non-health professional from United States on 2007-03-12

Patient: 43 year old female, weighing 54.4 kg (119.7 pounds)

Adverse reactions / side effects: Gastrointestinal Motility Disorder, Intra-Uterine Death, Drug Exposure Before Pregnancy, Constipation, Twin Pregnancy, Abdominal Discomfort, Drug Exposure During Pregnancy, Swelling, Hypertension, Cardiac Failure Congestive, Infarction

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Suspect drug(s):
Duragesic-50
    Dosage: patch see instructions transdermal
    Indication: Abdominal Pain Upper

Duragesic-50
    Dosage: patch see instructions transdermal
    Indication: Gastrointestinal Disorder

Actiq
    Dosage: 600 - 800mcg all day
    Indication: Abdominal Pain Upper

Actiq
    Dosage: 600 - 800mcg all day
    Indication: Gastrointestinal Disorder

Actiq
    Dosage: 600 - 800mcg all day
    Indication: OFF Label USE

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009